1. Chloroquine (CQ) exerts anti-breast cancer through modulating microenvironment and inducing apoptosis
   Yanjun Zhang et al, 2017, International Immunopharmacology CrossRef
2. Clinical Significance of Negative Costimulatory Molecule PD-1/PD-L1 on Peripheral Blood Regulatory T Cell Levels among Patients with Pulmonary Tuberculosis
   Chenchen Yang et al, 2022, Journal of Tropical Medicine CrossRef
3. Advancing CAR T-Cell Therapy for Solid Tumors: Lessons Learned from Lymphoma Treatment
   Aleksei Titov et al, 2020, Cancers CrossRef
4. CDX-585, a Bispecific Antibody with Dual Targeting of ILT4 and PD-1 Checkpoint Pathways
   Michael B. Murphy et al, 2023, Immuno CrossRef
5. Immune-Phenotyping and Transcriptomic Profiling of Peripheral Blood Mononuclear Cells From Patients With Breast Cancer: Identification of a 3 Gene Signature Which Predicts Relapse of Triple Negative Breast Cancer
   Gemma A. Foulds et al, 2018, Frontiers in Immunology CrossRef
6. Prognostic role of myeloid-derived suppressor cells in cancers: a systematic review and meta-analysis
   Lisha Ai et al, 2018, BMC Cancer CrossRef
7. Identification of monocyte-like precursors of granulocytes in cancer as a mechanism for accumulation of PMN-MDSCs
   Jérôme Mastio et al, 2019, Journal of Experimental Medicine CrossRef
8. Mechanisms Underlying the Role of Myeloid-Derived Suppressor Cells in Clinical Diseases: Good or Bad
   Yongtong Ge et al, 2021, Immune Network CrossRef
9. Myeloid derived suppressor cells in tumor microenvironment: Interaction with innate lymphoid cells
   Nicola Tumino et al, 2022, Seminars in Immunology CrossRef
10. Peripheral Blood Mononuclear Cell Populations Correlate with Outcome in Patients with Metastatic Breast Cancer
    Anna-Maria Larsson et al, 2022, Cells CrossRef
11. Role of immune regulatory cells in breast cancer: Foe or friend?
    Huan-Rong Lan et al, 2021, International Immunopharmacology CrossRef
12. Cancer-associated immune cells and their modulation by melatonin
    Shirin Hekmatirad et al, 2023, Immunopharmacology and Immunotoxicology CrossRef
13. Leveraging the Dynamic Immune Environment Triad in Patients with Breast Cancer: Tumour, Lymph Node, and Peripheral Blood
    Isobelle Wall et al, 2022, Cancers CrossRef
14. The Role of Myeloid-Derived Suppressor Cells in Tumor Growth and Metastasis
    Defne Bayik et al, 2022, Interaction of Immune and Cancer Cells CrossRef
15. In silico simulation of a clinical trial with anti-CTLA-4 and anti-PD-L1 immunotherapies in metastatic breast cancer using a systems pharmacology model
    Hanwen Wang et al, 2019, Royal Society Open Science CrossRef
16. The prognostic value of myeloid derived suppressor cell level in hepatocellular carcinoma: A systematic review and meta-analysis
    Xinyu Zhang et al, 2019, PLOS ONE CrossRef
17. Myeloid-derived suppressor cells coming of age
    Filippo Veglia et al, 2018, Nature Immunology CrossRef
18. Immune suppressive activity of myeloid-derived suppressor cells in cancer requires inactivation of the type I interferon pathway
    Kevin Alicea-Torres et al, 2021, Nature Communications CrossRef
19. Frequency of CD4+ regulatory T cells, CD8+ T cells, and human papilloma virus infection in Egyptian Women with breast cancer
    Amany M Tawfeik et al, 2020, International Journal of Immunopathology and Pharmacology CrossRef
20. The detection and clinical significance of peripheral regulatory CD4+CD25hiCD127low T cells in patients with non-small cell lung cancer
    J. Qiu et al, 2019, Clinical and Translational Oncology CrossRef
21. The Biomarkers of Cd4+ T Regulatory Cells Associated with Tumour Immune Escape
    MC Nyaribari, 2020, International Journal of Immunotherapy and Cancer Research CrossRef
22. The Peripheral Immune Landscape of Breast Cancer: Clinical Findings and In Vitro Models for Biomarker Discovery
    Sofia Batalha et al, 2021, Cancers CrossRef